In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WuXi's Customer Focused Business Model Shows the Changing Relationship Between Drug Makers and CROs

Executive Summary

Beset by the hurdlesand dynamics of drug discovery, service providers have evolved from traditional vendors performing non-core support to their pharma and biotech customers, to becoming critical partners. WuXi has adapted quickly to seize new opportunities.
Advertisement

Related Content

China: The Asian Dragon Lures Foreign Investors
China: The Asian Dragon Lures Foreign Investors

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003333

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel